The President's Council on Bioethics (PCBE) was a group of individuals appointed by United States President George W. Bush to advise his administration on bioethics. Established on November 28, 2001, by Executive Order 13237, the council was directed to "advise the President on bioethical issues that may emerge as a consequence of advances in biomedical science and technology". [1] It succeeded and largely replaced the National Bioethics Advisory Commission, appointed by President Bill Clinton in 1996, which expired in 2001.
The members of the council were appointed directly by the President; the President also chose the chairperson of the council (last appointed Chair was Edmund D. Pellegrino). Council members, totaling no more than 18, were appointed for a two-year term, after which time they could be reappointed by the President. Individuals appointed could not be officers or employees of the federal government. Executive Order 13237 was renewed in 2003, 2005 and again in 2007. [2]
In June 2009, President Barack Obama's administration informed members of the council that their services were no longer needed. [3] Through a spokesperson, Obama made clear that he intended to replace the committee with a body that "offers practical policy options" rather than philosophical guidance. [3]
Executive Order 13521 of November 24, 2009, superseded the previous council by establishing the Presidential Commission for the Study of Bioethical Issues. [4] On November 25, 2009, Obama named Amy Gutmann, the president of the University of Pennsylvania, to chair his new advisory panel on bioethics. James W. Wagner, the president of Emory University, was appointed vice chairperson. [5]
Critics have questioned the motives and goals of the PCBE. Elizabeth Blackburn, who was dismissed from the Commission, co-authored an article, citing examples published by other members, suggesting that it was set up to justify President Bush's positions on stem cell research and abortion, writing "...our concern is that some of their contents... may have ended up distorting the potential of biomedical research and the motivation of some of its researchers." [6] [7]
Bioethicist Leslie A. Meltzer accused the council of wrapping "political and religious agendas in the guise of dignity," and described them as largely Christian-affiliated neoconservatives; philosophers and political scientists rather than bench scientists. Meltzer said that Council members mischaracterized the positions of their opponents and used invective rather than addressing the merits of the arguments. [8]
The response to President Obama's decision to disband the council drew both criticism and praise. Colleen Carroll Campbell, a former speechwriter for President Bush and a member of the conservative advocacy group Ethics and Public Policy Center predicted that "Obama's desire to see his policies backed by expert 'consensus' more likely will be realized with a new commission composed of like-minded political liberals steeped in utilitarianism than with the brainy, diverse and unpredictable crew that populated the now-defunct council." [9] In contrast, Jacob M. Appel of New York's Mount Sinai Hospital wrote that "the panel itself, far from being an incubator of intellectual ferment, had evolved into a publicly funded right-wing think tank with a handful of token moderates for window dressing" and argued that "Obama was wise to scrap the entire panel and to start over." [10]
S1909/A2840 is a bill that was passed by the New Jersey Legislature in December 2003, and signed into law by Governor James McGreevey on January 4, 2004, that permits human cloning for the purpose of developing and harvesting human stem cells. Specifically, it legalizes the process of cloning a human embryo, and implanting the clone into a womb, provided that the clone is then aborted and used for medical research. The legislation was sponsored by Senators Richard Codey (D-Essex) and Barbara Buono, and Assembly members Neil M. Cohen (D-Union), John F. McKeon, Mims Hackett (D-Essex), and Joan M. Quigley (D-Hudson). The enactment of this law will enable researchers to find cures for debilitating and deadly diseases.
The National Academy of Medicine (NAM), known as the Institute of Medicine (IoM) until 2015, is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC).
The President's Intelligence Advisory Board (PIAB) is an advisory body to the Executive Office of the President of the United States. According to its self-description, it "provides advice to the President concerning the quality and adequacy of intelligence collection, of analysis and estimates, of counterintelligence, and of other intelligence activities."
Leon Richard Kass is an American physician, scientist, educator, and public intellectual. Kass is best known as a proponent of liberal arts education via the "Great Books," as a critic of human cloning, life extension, euthanasia and embryo research, and for his tenure as chairman of the President's Council on Bioethics from 2001 to 2005. Although Kass is often referred to as a bioethicist, he eschews the term and refers to himself as "an old-fashioned humanist. A humanist is concerned broadly with all aspects of human life, not just the ethical."
Elizabeth Helen Blackburn, is an Australian-American Nobel laureate who is the former president of the Salk Institute for Biological Studies. In 1984, Blackburn co-discovered telomerase, the enzyme that replenishes the telomere, with Carol W. Greider. For this work, she was awarded the 2009 Nobel Prize in Physiology or Medicine, sharing it with Carol W. Greider and Jack W. Szostak, becoming the first Australian woman Nobel laureate.
Amy Gutmann is an American academic and diplomat who has served as the United States Ambassador to Germany since 2022. She was previously the president of the University of Pennsylvania from 2004 to 2022, the longest-serving president in the history of the University of Pennsylvania.
Bartha Maria Knoppers, OC OQ is a Canadian law Professor and an expert on the ethical aspects of genetics, genomics and biotechnology.
The stem cell controversy concerns the ethics of research involving the development and use of human embryos. Most commonly, this controversy focuses on embryonic stem cells. Not all stem cell research involves human embryos. For example, adult stem cells, amniotic stem cells, and induced pluripotent stem cells do not involve creating, using, or destroying human embryos, and thus are minimally, if at all, controversial. Many less controversial sources of acquiring stem cells include using cells from the umbilical cord, breast milk, and bone marrow, which are not pluripotent.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research was the first public national body to shape bioethics policy in the United States.
Jonathan D. Moreno is an American philosopher and historian who specializes in the intersection of bioethics, culture, science, and national security, and has published seminal works on the history, sociology and politics of biology and medicine. He is an elected member of the National Academy of Medicine.
The Nuffield Council on Bioethics is a UK-based independent charitable body, which examines and reports on bioethical issues raised by new advances in biological and medical research. Established in 1991, the Council is funded by the Nuffield Foundation, the Medical Research Council and the Wellcome Trust. The Council has been described by the media as a 'leading ethics watchdog', which 'never shrinks from the unthinkable'.
Stem cell laws are the law rules, and policy governance concerning the sources, research, and uses in treatment of stem cells in humans. These laws have been the source of much controversy and vary significantly by country. In the European Union, stem cell research using the human embryo is permitted in Sweden, Spain, Finland, Belgium, Greece, Britain, Denmark and the Netherlands; however, it is illegal in Germany, Austria, Ireland, Italy, and Portugal. The issue has similarly divided the United States, with several states enforcing a complete ban and others giving support. Elsewhere, Japan, India, Iran, Israel, South Korea, China, and Australia are supportive. However, New Zealand, most of Africa, and most of South America are restrictive.
Stem cell laws and policy in the United States have had a complicated legal and political history.
Human subject research legislation in the United States can be traced to the early 20th century. Human subject research in the United States was mostly unregulated until the 20th century, as it was throughout the world, until the establishment of various governmental and professional regulations and codes of ethics. Notable – and in some cases, notorious – human subject experiments performed in the US include the Tuskegee syphilis experiment, human radiation experiments, the Milgram obedience experiment and Stanford prison experiments and Project MKULTRA. With growing public awareness of such experimentation, and the evolution of professional ethical standards, such research became regulated by various legislation, most notably, those that introduced and then empowered the institutional review boards.
The Presidential Commission for the Study of Bioethical Issues was created by Executive Order 13521 on November 24, 2009. The Bioethics Commission advised President Barack Obama on bioethical issues arising from advances in biomedicine and related areas of science and technology. It replaced The President's Council on Bioethics appointed by United States President George W. Bush to advise his administration on bioethics, and the National Bioethics Advisory Commission (1996-2001). No national organization replaced it when its authorization expired; it "held its final meeting at the end of August 2016 and closed its doors."
Carlo Petrini is an Italian scientist and Director of Researh at the Italian National Institute of Health, where he is head of the Bioethics Unit.
Françoise Elvina BaylisFISC is a Canadian bioethicist whose work is at the intersection of applied ethics, health policy, and practice. The focus of her research is on issues of women's health and assisted reproductive technologies, but her research and publication record also extend to such topics as research involving humans, gene editing, novel genetic technologies, public health, the role of bioethics consultants, and neuroethics. Baylis' interest in the impact of bioethics on health and public policy as well as her commitment to citizen engagement]and participatory democracy sees her engage with print, radio, television, and other online publications.
Ranbir Chander Sobti is an Indian educationist, cell biologist. He is a former vice chancellor of the Panjab University, Chandigarh and Babasaheb Bhimrao Ambedkar University, Lucknow. He is known to have involved in advanced research in plant genetic studies and has written over 240 articles, and 22 books including Essentials of Biotechnology and Emerging Trends in Biomedical Science and Health. He is an elected Fellow of several major science academies such as Indian National Science Academy, National Academy of Agricultural Sciences, National Academy of Medical Sciences, National Academy of Sciences, India, and Punjab Academy of Sciences. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2009, for his contributions to Literature and Education.
Patricia A. King is a professor of law emeritus at Georgetown University Law Center and an adjunct professor in the School of Hygiene and Public Health at Johns Hopkins University. Her expertise lies at the intersection of law, medicine, ethics, and public policy. In 1979, she became the first African-American woman law professor to receive tenure at Georgetown.